Research studies have demonstrated reductions in body weight gain and increased lipolytic activity in adipose tissue
Our API sourcing protocol includes certificate of analysis review, third-party analytical testing, and periodic supplier audits to ensure consistent purity, potency, and sterility standards across all product lines
Here is what the evidence shows
Interestingly, research has shown that even in animals lacking beta-3 adrenergic receptors, acute AOD-9604 administration still increased energy expenditure and fat oxidation, suggesting additional metabolic pathways may be involved beyond the primary beta-3 receptor mechanism
By modulating this pathway, researchers explore how it may support investigations into metabolic energy balance, adipose response, and overall metabolic health
The primary study and use of AOD-9604 is for fat metabolism support, not muscle or athletic recovery